AGC Biologics Expands Deal With Novelty Nobility For Antibody Production
Chiba: AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), has expanded its manufacturing agreement with South Korea-based biotech company Novelty Nobility to advance a bispecific antibody drug candida…